ABBOTT LABORATORIES (ABT) 98.33 -1.51 (-1.51%)
98.33 -1.51 (-1.51%)
US0028241000 - Common Stock - After market: 98.33 0 (0%)
| MRQ (2022-6-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 8.94B | 9.80B | 6.84B | 3.86B | 3.84B | |||
| Treasury Stock | -13.72B | -11.82B | -10.04B | -10.15B | -9.96B | |||
| Marketable Securities | 353.00M | 450.00M | 310.00M | 280.00M | 242.00M | |||
| Receivables | 7.20B | 6.49B | 6.41B | 5.42B | 5.18B | |||
| Inventories | 5.90B | 5.16B | 5.01B | 4.32B | 3.80B | |||
| Other Current Assets | 2.57B | 2.35B | 1.87B | 1.79B | 1.57B | |||
| Total Current Assets | 24.96B | 24.24B | 20.44B | 15.67B | 14.63B | |||
| Non-Current Assets | ||||||||
| PPE Net | 8.82B | 10.11B | 10.13B | 8.97B | 7.56B | |||
| Investments And Advances | 734.00M | 816.00M | 821.00M | 883.00M | 897.00M | |||
| Intangibles | 11.59B | 12.74B | 14.78B | 17.02B | 18.94B | |||
| Other Non-Current Assets | 5.36B | 4.06B | 2.63B | 2.15B | 1.89B | |||
| Other Assets | 22.74B | 23.23B | 23.74B | 23.20B | 23.25B | |||
| Total Non-Current Assets | 49.25B | 50.96B | 52.11B | 52.22B | 52.54B | |||
| TOTAL ASSETS | 74.20B | 75.20B | 72.55B | 67.89B | 67.17B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 213.00M | 201.00M | 200.00M | |||
| Accounts Payable And Accrued Liabilities | 4.49B | 4.41B | 3.95B | 3.25B | 2.98B | |||
| Accrued Expenses | 6.71B | 6.81B | 6.58B | 5.18B | 4.87B | |||
| Other Current Liabilities | 1.18B | 1.14B | 1.16B | 950.00M | 963.00M | |||
| Total Current Liabilities | 12.39B | 13.11B | 11.91B | 10.86B | 9.01B | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 16.75B | 17.30B | 18.53B | 16.11B | 19.36B | |||
| Deferred Taxes/Income | N/A | 1.39B | 1.41B | 1.55B | 2.06B | |||
| Other Non-Current Liabilities | 8.34B | 7.38B | 7.71B | 8.06B | 6.02B | |||
| Total Non-Current Liabilities | 25.32B | 26.29B | 27.86B | 25.94B | 27.64B | |||
| TOTAL LIABILITIES | 37.71B | 39.39B | 39.76B | 36.80B | 36.65B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Minority Interest | 226.00M | 222.00M | 219.00M | 213.00M | 198.00M | |||
| Shares Outstanding | 1.75B | 1.76B | 1.77B | 1.76B | 1.76B | |||
| Common Shares | 24.43B | 24.47B | 24.14B | 23.85B | 23.51B | |||
| Retained Earnings | 34.49B | 31.53B | 27.63B | 25.85B | 24.56B | |||
| Other Shareholders' Equity | -8.71B | -8.37B | -8.95B | -8.46B | -7.59B | |||
| Total Shareholders' Equity | 36.49B | 35.80B | 32.78B | 31.09B | 30.52B | |||
| TOTAL LIABILITIES AND EQUITY | 74.20B | 75.20B | 72.55B | 67.89B | 67.17B | |||
| Statistics | ||||||||
| Debt/Equity | 0.46 | 0.48 | 0.57 | 0.52 | 0.63 | |||
| Current Ratio | 2.01 | 1.85 | 1.72 | 1.44 | 1.62 | |||
| Return On Assets (ROA) | 11.53% | 9.40% | 6.20% | 5.43% | 3.53% | |||
| Return On Equity (ROE) | 23.44% | 19.75% | 13.71% | 11.86% | 7.76% | |||
All data in USD